1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

World’s First ICD Treats Cardiac Arrest without Touching the Heart

Dr. Kanner recently implanted the S-ICD® System, the world’s first and only ICD that functions without leads

 
PRLog - May 1, 2014 - OCEANSIDE, N.Y. -- A breakthrough treatment alternative to the traditional implantable cardio-defibrillator (ICD) provides patients at risk for sudden cardiac arrest (SCA) with the same potentially-lifesaving protection, but without touching the heart.

Lawrence Kanner, MD, FACC, director of electrophysiology and arrhythmia services at South Nassau Communities Hospital, recently implanted the S-ICD® System, the world’s first and only implantable cardioverter-defibrillator that functions without leads (also known as electrodes – the thin, insulated wires attached to a typical ICD)  placed into the heart.

The S-ICD System provides defibrillation therapy for the treatment of life-threatening rapid heart rhythms in patients who do not require pacemaker support and whose rapid heart rhythms are not reliably terminated with pacing.

SCA is an abrupt loss of heart function.  Most episodes are caused by a rapid and/or chaotic heart beat or ventricular fibrillation (the uncoordinated contraction of the cardiac muscle of the ventricles of the heart).  Recent estimates show that approximately 850,000 people in the United States are at risk of SCA and would benefit from an ICD device, but remain unprotected. Each year, SCA claims the lives of up to 460,000 people in the U.S. alone, and more people die from it than from lung cancer, breast cancer and AIDS combined.

“ICDs and CRT-Ds have been proven in clinical studies to save and extend lives by preventing sudden cardiac death (SCD) and treating heart failure,” added Dr. Kanner.

The S-ICD System has two main components: (1) the generator, which powers the system, monitors heart activity, and delivers a shock if needed, and (2)the electrode, which enables the device to sense the cardiac rhythm and deliver shocks when necessary.  Both components are implanted just under the skin—the generator at the side of the chest, and the electrode beside the breastbone.  Unlike traditional transvenous ICDs, which are inserted through a vein, the heart and blood vessels remain untouched with the S-ICD system.  Implantation with the S-ICD System is straightforward, using anatomical landmarks, and does not require fluoroscopy (an x-ray procedure that makes it possible to see internal organs in motion). Fluoroscopy is required for implanting the leads attached to typical transvenous ICD systems.

Dr. Kanner and South Nassau’s Center for Cardiovascular Health have been in the forefront in providing heart failure patients on Long Island with the latest advancements in ICD devices and electrophysiology services.  Dr. Kanner was the first electrophysiologist on Long Island to implant several groundbreaking cardiac devices: the Viva® cardiac resynchronization therapy device with defibrillation (CRT-D) (which continuously adjusts to individual patient needs and preserves each patient’s normal heart rhythms; Incepta® ICD (recognized as the world’s smallest and thinnest ICD); Evia® pacemaker (which incorporates a wireless monitoring system that immediately notifies the patient’s physician if the patient or the pacemaker is experiencing complications) and was among the first to implant the Revo MRI™ SureScan® pacing system (the first pacemaker in the U.S. specifically designed for use in a MRI environment).

In addition to ICDs, Dr. Kanner and electrophysiologists at the Center for Cardiovascular Health use an array of other advanced technologies and treatments to provide timely, accurate diagnoses and therapies for the range of cardiac arrhythmias.  This includes diagnostic studies, defibrillator maintenance, implanting and testing of pacemakers, and radiofrequency catheter ablation.

Designated a Magnet® hospital by the American Nurses Credentialing Center (ANCC), South Nassau® Communities Hospital is one of the region’s largest hospitals, with 435 beds, more than 900 physicians and 3,000 employees.  Located in Oceanside, NY, the hospital is an acute-care, not-for-profit teaching hospital that provides state-of-the-art care in cardiac, oncologic, orthopedic, bariatric, pain management, mental health and emergency services.  In addition to its extensive outpatient specialty centers, South Nassau provides emergency and elective angioplasty, and is the only hospital on Long Island with the Novalis Tx™ and Gamma Knife® radiosurgery technologies.  South Nassau is a designated Stroke Center by the New York State Department of Health and Comprehensive Community Cancer Center by the American College of Surgeons and is an accredited center of the Metabolic and Bariatric Surgery Association and Quality Improvement Program.  In addition, the hospital has been awarded the Joint Commission’s gold seal of approval as a Top Performer on Key Quality Measures, including heart attack, heart failure, pneumonia and surgical care; and disease-specific care for hip and joint replacement, wound care and end-stage renal disease. For more information, visit www.southnassau.org.

Media Contact
South Nassau Communities Hospital
516-377-5370
***@snch.org

--- End ---

Click to Share

Contact Email:
***@snch.org Email Verified
Source:South Nassau Communities Hospital
City/Town:Oceanside - New York - United States
Industry:Health, Medical
Tags:pacemaker, defibrillator, icd, sudden cardiac arrest, electrophysiologist
Shortcut:prlog.org/12317663
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share